Canada Pension Plan Investment Board
ENTA icon

Canada Pension Plan Investment Board’s Enanta Pharmaceuticals ENTA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,900
Closed -$140K – 1790
2025
Q4 		$140K Buy
+8,900
New +$113K ﹤0.01% 1749
2014
Q2 		– Sell
-1,300
Closed -$52K – 1247
2014
Q1 		$52K Buy
+1,300
New +$47.2K ﹤0.01% 1134

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Canada Pension Plan Investment Board's ENTA Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Enanta Pharmaceuticals (ENTA) in Q1 2026, closing a stake of 8,900 shares — an estimated $140K sold.

Canada Pension Plan Investment Board first reported a position in ENTA in Q1 2014 and held it in 2 quarters. The position peaked at $140K in Q4 2025. 133 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Enanta Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 8,900 Enanta Pharmaceuticals shares in Q1 2026, an estimated $140K.
  • Canada Pension Plan Investment Board first reported a position in Enanta Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Enanta Pharmaceuticals position peaked at $140K in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.